Zocor Lawsuit

Zocor lawsuits may be filed by patients for side effects of the cholesterol drug. If you have been adversely affected by the statin Zocor, contact an attorney to discuss your compensation options.

New FDA warnings suggest that the cholesterol-lowering medication Zocor may no longer be considered safe, due to the risk of severe muscle injury side effects. Zocor (simvastatin) has been available in the U.S. since 1991 and belongs to a class of medications called HMG CoA reductase inhibitors. These drugs function by reducing the levels of bad cholesterol (low-density lipoproteins) in the blood, while increasing the levels of good cholesterol (high-density lipoproteins). Zocor is currently manufactured by Merck & Co. and is commonly prescribed to lower the risk of heart attack, stroke and other heart problems in patients with coronary heart disease, diabetes, and other risk factors. If you took Zocor to control your cholesterol and have since suffered from a major side effect, fill out the Zocor Claim Review Form to explore your compensation options.

What Went Wrong With Zocor

Despite the fact that Zocor has been on the U.S. market for twenty years, recent studies have exposed the statin drug's potential to cause serious side effects among patients, including myopathy (muscle injury), rhabdomyolysis and kidney damage. In fact, this Zocor side effect risk is so high that the FDA recently restricted the use of high-dose Zocor, citing research that found that patients taking Zocor 80mg daily had an increased risk of muscle injury compared to patients taking lower doses of Zocor or other statin drugs.

Zocor Lawsuits for Side Effects

Over the past few years, the FDA has issued several warnings concerning Zocor side effects like myopathy and rhabdomyolysis. In 2010, the FDA released a warning notifying patients and physicians about the potential increased risk of muscle injury associated with the cholesterol-lowering drug Zocor 80mg. Although myopathy is a known side effect of all statins, the FDA announcement specifically highlighted the increased risk of developing muscle injury, including rhabdomyolysis, in patients taking higher dose Zocor. In 2011, the FDA announced new safety recommendations for high-dose Zocor based on the link between the highest approved dose of Zocor (80mg) and an elevated risk of myopathy, particularly during the first 12 months of use. The FDA advised that Zocor 80mg only be used in patients who have been taking the medication for 12 months or more, with no sign of muscle toxicity.

How a Zocor Lawsuit Can Help You

If you took the statin drug Zocor and have since experienced a serious muscle injury side effect, contact a Zocor attorney to discuss the benefits of filing a Zocor lawsuit against Merck & Co. The main goal of Zocor lawsuits is to help injured victims protect their rights and seek financial compensation for their injuries, medical expenses, and pain and suffering. Filing a Zocor lawsuit can be a complicated process. Fortunately, Zocor lawyers are experienced in defective drug litigation, and can help victims of potential Zocor side effects collect the information they need to develop a strong case.

How to File a Zocor Lawsuit

Muscle injury side effects like myopathy and rhabdomyolysis are extremely dangerous and can lead to potentially fatal side effects like kidney damage and kidney failure. If you or a loved one has suffered from a muscle injury side effect, and you believe Zocor to be the cause, fill out the Zocor Claim Review Form to speak to a qualified Zocor attorney. You are not fault for any injuries caused by a dangerous pharmaceutical drug. Drug companies like Merck are expected to produce safe medications, and should be held accountable for any adverse side effects sustained by consumers of their products. Unfortunately, this isn't always the case. By hiring a Zocor lawyer and filing a Zocor lawsuit against Merck, injured patients can collect the compensation they deserve and hold the allegedly negligent drug company liable for their injuries.





Prescription Drugs in The News